Sartorius Stedim Biotech's total assets for Q2 2026 were €7.92B, a decrease of -3.32% from the previous quarter. MX:DIMN total liabilities were €3.67B for the fiscal quarter, a -9.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.